Hoth said that its legacy biotechnology programs will continue under a wholly owned subsidiary. The company said its shares ...

Rocket One announced its entry into AMD’s AI Developer Program to gain access to AI development resources, technical training ...

Hoth Therapeutics’ search for salvation in the stars appears to have been rewarded by investors, as the company’s stock ...

Company Adopts Space-Focused Identity, New Ticker "RKTO," and Exclusive License of AI Chip Architecture Designed for Ultra-Low-Power, Radiation-Tolerant Computing in Space and Defense Applications ...

Hoth Therapeutics HOTH shares are trading sharply higher in after-hours trading Tuesday. HOTH shares surged 27.94% to $1.74 ...

Hoth Therapeutics is rebranding as Rocket One and pivoting toward space-focused AI chip infrastructure, targeting low-power, ...

On May 20, 2026, Rocket One Inc. (formerly Hoth Therapeutics, Inc.) filed an amendment in Nevada to change its corporate name from Hoth Therapeutics to Rocket One Inc., with the name change becoming ...

NEW YORK, March 27, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced the entry into a definitive agreement for the immediate ...

In the open-label PK cohort, 100% of evaluable patients achieved clinical response by Week 6, accompanied by an approximate 50% reduction in investigator-assessed disease severity (using the ARIGA ...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Hoth Therapeutics HOTH is a clinical-stage ...